Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,472.3
21.5 (0.88%)

 

  • STI Straits Times Index
    2,472.3
    21.5 (0.88%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.1
    8.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,235.4
    -75.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,219.4
    -3.8 (-0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,204.6
    116.8 (0.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,945.8
    103.0 (2.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.2M
  • Value: 869.4M
  • Rise: 172
  • Fall: 134
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.051+0.005
Sembcorp Marine0.142-0.002
Alset0.062-0.001
Samko Timber0.034+0.001
Avarga0.260+0.015
AnAn Intl0.033+0.004
Addvalue Tech0.024+0.001
Rex Intl0.146+0.003
Singtel2.140+0.020
ThaiBev0.585-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

REATA PHARMACEUTICALS INC REATA PHARMACEUTICALS, INC. CLASS A
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 93.830 Change: -8.910 High: 103.460 Remarks: -
Change (%): -8.67 Low: 92.000
Open 102.900 Yesterday's Close 102.74
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 803,116 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -8.63151 Trailing EPS (USD) e -10.20765 NAV (USD) b 6.8901
PE a - Trailing PE f - Price / NAV b 13.6181
Dividend (USD) d - Cash In Hand (USD) g 18.1578 Issued & Paid-up Shares c 28,559,200
Dividend Yield (%) d - Price / Cash In Hand g 5.167 Treasury Shares h -
Market Cap (M) 3,154.332 Enterprise Value (M) 2,916.866
Piotroski F Score 0 Exchange Code RETA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 103.26 Free Float (%) 93.4
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 May 2016.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference REATA PHARMACEUTICALS INC NASDAQ 3,154.332 - - 13.6181 -
Industry Pharmaceuticals: Major NASDAQ 2,600.863 114.250 71.024 4.0822 0.005
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 145,690.436 - - - 2.468
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 127,857.439 39.296 10.409 1.7983 2.302
Local Peer ROYALTY PHARMA PLC NASDAQ 24,326.737 10.358 10.358 5.8518 -
Local Peer CUREVAC NV NASDAQ 7,839.490 - - -163.6330 -
Local Peer REPLIGEN CORP NASDAQ 7,576.125 353.841 244.873 6.8872 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,675.715 - - 13.6668 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,331.812 6.191 7.037 0.7189 2.680
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,104.067 - - 10.2347 -
Local Peer ALLAKOS INC NASDAQ 3,926.792 - - 8.7847 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 3,655.622 - - 5.1428 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,322.510 - - 9.4540 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,150.429 - - 2.5078 -
Other Local Peers I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), QUANTERIX CORPORATION (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PROVENTION BIO INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TRICIDA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BEYONDSPRING INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), AC IMMUNE SA (NASDAQ), IMMUNIC INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), MUSTANG BIO INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), GENPREX INC (NASDAQ), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), MEDIWOUND LTD (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), NOVAN INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 383,496.561 25.365 25.255 6.0894 2.574
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 214,905.597 30.491 29.773 3.9937 2.115
Global Peer MERCK & CO INC NYSE 209,749.873 21.310 20.016 7.5881 2.736
Global Peer PFIZER INC NYSE 200,325.524 12.311 14.137 3.1137 4.033
Global Peer ABBVIE INC NYSE 152,181.291 19.406 22.049 10.3469 4.266
Global Peer ELI LILLY AND COMPANY NYSE 143,719.182 30.988 25.581 35.1140 1.719
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,086.296 38.990 - 2.7312 2.792
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,175.394 21.437 20.408 13.8319 1.647
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 94,828.104 16.003 14.832 5.6460 5.160
Global Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 58,421.013 143.577 59.119 1.3448 -
Other Global Peers WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HYGEIA HEALTH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), CMS (HKEx), HEPALINK (HKEx), AKESO-B (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), OCUMENSION-B (HKEx), SSY GROUP (HKEx), INNOCARE-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), Kimia Farma Tbk. (IDX), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), Soho Global Health Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), PHARMA (Bursa), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), ZHONGZHIPHARM (HKEx), CH BIOTECH SER (HKEx), BIOMX INC (NYSE American), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), KOTRA (Bursa), Merck Tbk. (IDX), Hyphens Pharma (SGX), NEW RAY MEDIC (HKEx), Phapros Tbk. (IDX), IP (SET), ONCOSIL MEDICAL LIMITED (ASX), NEP INTERLONG (HKEx), PAK FAH YEOW (HKEx), RACE ONCOLOGY LTD (ASX), NOVA (Bursa), PALLA PHARMA LTD (ASX), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NOXOPHARM LTD (ASX), NC HEALTHCARE (HKEx), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), MEDLAB CLINICAL LIMITED (ASX), JCT (SET), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), EXOPHARM LTD (ASX), PHARMAXIS (ASX), SUNZEN (Bursa), ACRUX (ASX), FIJI KAVA LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CRESO PHARMA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --11.660
-11.05 %
10 Days --5.260
-5.31 %
20 Days --12.210
-11.51 %
Medium Term Return 3 Months --69.340
-42.50 %
6 Months --56.160
-37.44 %
1 Year -+9.580
+11.37 %
Long Term Return 2 Years -+12.070
+14.76 %
3 Years -+62.730
+201.70 %
Annualised Return Annualised --
+44.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 73.380 - 257.965 Change From 1 Year Low +20.450 % Change From 1 Year Low (%) +27.87
Change From 1 Year High -164.135 % Change From 1 Year High (%) -63.63
2 Years Range 47.500 - 257.965 Change From 2 Years Low +46.330 % Change From 2 Years Low (%) +97.54
Change From 2 Years High -164.135 % Change From 2 Years High (%) -63.63
5 Years Range 11.030 - 257.965 Change From 5 Years Low +82.800 % Change From 5 Years Low (%) +750.68
Change From 5 Years High -164.135 % Change From 5 Years High (%) -63.63
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 102.900 103.460 92.000 93.830 803,116 -
24 Sep 2020 107.060 107.060 99.500 102.740 349,189 -
23 Sep 2020 110.930 117.000 108.520 108.610 370,887 -
22 Sep 2020 105.010 111.790 102.770 111.110 408,243 -
21 Sep 2020 103.100 104.650 102.220 104.420 218,327 -
18 Sep 2020 104.300 105.753 100.840 105.490 480,105 -
17 Sep 2020 104.290 104.290 100.060 103.360 275,483 -
16 Sep 2020 101.690 106.390 101.060 105.210 487,876 -
15 Sep 2020 102.980 103.670 100.550 101.310 287,631 -
14 Sep 2020 100.310 103.520 100.310 101.480 236,440 -
11 Sep 2020 101.280 102.000 96.510 99.090 259,653 -
10 Sep 2020 100.070 102.668 98.458 100.300 378,011 -
09 Sep 2020 98.460 102.370 98.370 100.790 266,579 -
08 Sep 2020 96.080 99.930 95.240 97.190 310,068 -
04 Sep 2020 100.800 101.043 95.450 97.360 305,276 -
03 Sep 2020 105.800 107.000 100.190 100.790 264,007 -
02 Sep 2020 104.990 107.230 102.600 105.890 181,849 -
01 Sep 2020 105.060 105.830 102.600 105.000 231,456 -
31 Aug 2020 105.610 106.670 104.130 104.950 226,517 -
28 Aug 2020 103.850 107.080 102.600 106.040 163,914 -
27 Aug 2020 101.990 104.650 100.550 104.170 225,964 -
26 Aug 2020 103.030 103.500 100.400 101.990 209,358 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
100.310 117.000 92.000 93.830 3,917,297 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
103.850 117.000 92.000 99.090 2,587,330 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
154.140 154.140 92.000 104.170 10,688,291 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.